(b) If the executive commissioner establishes a program underneath this subchapter, the commissioner shall publish a report not later on than January 1 of each odd-numbered calendar year over the medical success of the use of tetrahydrocannabinols as well as their derivatives and any other health care findings with the investigation software.(A) a